Terushkin today and take the next step toward better health
by Dennis Crouch Since late 2022, the extraordinary demand for glucagon-like peptide-1 receptor agonists (GLP-1s) like Eli Lilly's tirzepatide (marketed as Mounjaro for diabetes and Zepbound for weight loss) has created a persistent nationwide shortage
Genetic factors are also implicated in the development of hypertension
Employees already taking the drugs will be briefly grandfathered in until either June 2025 or the expiration of their prescription authorization, whichever comes first
Ongoing Monitoring : Peptides like PDA should complement a broader wellness plan, including proper nutrition, exercise, and other therapies
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbll T, SUSTAIN-6 Investigators